Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Daniel Jeong in Pancreatic Cancer Research
Introduction
Daniel Jeong is a notable inventor based in Tampa, Florida, recognized for his significant contributions to the field of pancreatic cancer research. His work focuses on developing advanced diagnostic tools that can enhance the management of pancreatic cancer and its precursors.
Latest Patents
Daniel Jeong holds a patent for "Theranostic tools for management of pancreatic cancer and its precursors." This invention involves materials and methods for identifying and classifying pancreatic ductal adenocarcinoma (PDAC) precursors or intraductal papillary mucinous neoplasm (IPMN). The patent utilizes messenger RNAs, microRNAs, long non-coding RNAs, radiomic features, and radiologic measures of abdominal/visceral obesity as diagnostic markers. These tools aim to integrate with clinical management and interventions for personalized care. He has 1 patent to his name.
Career Highlights
Daniel Jeong is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where he contributes to groundbreaking research in cancer diagnostics and treatment. His work is pivotal in advancing the understanding and management of pancreatic cancer.
Collaborations
Throughout his career, Daniel has collaborated with esteemed colleagues, including Jennifer Permuth and Jung Wook Choi. These partnerships enhance the research efforts and contribute to the development of innovative solutions in cancer care.
Conclusion
Daniel Jeong's innovative work in pancreatic cancer research exemplifies the importance of advancements in medical diagnostics. His contributions are vital for improving patient outcomes and personalizing cancer treatment strategies.